| 日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 24/09/2026 | 曲繼廣 | 1113(L) | +700,000(L) | HKD2.793(L) | 1,280,142,000(L) | 43.37 |
| 23/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,250,000(L) | HKD2.797(L) | 922,704,000(L) | 31.26 |
| 23/09/2026 | 曲繼廣 | 1113(L) | +1,250,000(L) | HKD2.797(L) | 1,279,442,000(L) | 43.35 |
| 22/09/2026 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.762(L) | 1,278,192,000(L) | 43.31 |
| 21/09/2026 | 曲繼廣 | 1113(L) | +800,000(L) | HKD2.750(L) | 1,277,192,000(L) | 43.27 |
| 18/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,150,000(L) | HKD2.734(L) | 921,454,000(L) | 31.22 |
| 18/09/2026 | 曲繼廣 | 1113(L) | +1,150,000(L) | HKD2.734(L) | 1,276,392,000(L) | 43.25 |
| 17/09/2026 | 曲繼廣 | 1113(L) | +1,400,000(L) | HKD2.768(L) | 1,275,242,000(L) | 43.21 |
| 17/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,400,000(L) | HKD2.768(L) | 920,304,000(L) | 31.18 |
| 16/09/2026 | 曲繼廣 | 1113(L) | +850,000(L) | HKD2.711(L) | 1,273,842,000(L) | 43.16 |
| 15/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,400,000(L) | HKD2.694(L) | 918,904,000(L) | 31.13 |
| 15/09/2026 | 曲繼廣 | 1113(L) | +1,400,000(L) | HKD2.694(L) | 1,272,992,000(L) | 43.13 |
| 15/09/2026 | UBS Group AG | 1502(S) | -577,491(S) | 164,967,814(L) 29,039,167(S) | 5.59 0.98 | |
| 14/09/2026 | 曲繼廣 | 1113(L) | +3,200,000(L) | HKD2.616(L) | 1,271,592,000(L) | 43.08 |
| 11/09/2026 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.621(L) | 1,268,392,000(L) | 42.98 |
| 11/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.621(L) | 917,504,000(L) | 31.09 |
| 10/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +870,000(L) | HKD2.623(L) | 916,504,000(L) | 31.05 |
| 10/09/2026 | 曲繼廣 | 1113(L) | +870,000(L) | HKD2.623(L) | 1,267,392,000(L) | 42.94 |
| 09/09/2026 | 曲繼廣 | 1113(L) | +880,000(L) | HKD2.731(L) | 1,266,522,000(L) | 42.91 |
| 09/09/2026 | China Pharmaceutical Company Limited | 1101(L) | +880,000(L) | HKD2.731(L) | 915,634,000(L) | 31.02 |
| 08/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,300,000(L) | HKD2.708(L) | 914,754,000(L) | 30.99 |
| 08/09/2026 | 曲繼廣 | 1113(L) | +1,300,000(L) | HKD2.708(L) | 1,265,642,000(L) | 42.88 |
| 07/09/2026 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.744(L) | 1,264,342,000(L) | 42.84 |
| 07/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.744(L) | 913,454,000(L) | 30.95 |
| 04/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +850,000(L) | HKD2.751(L) | 912,454,000(L) | 30.91 |
| 04/09/2026 | 曲繼廣 | 1113(L) | +850,000(L) | HKD2.751(L) | 1,263,342,000(L) | 42.80 |
| 24/06/2026 | UBS Group AG | 1213(L) | -4,574,000(L) | 172,627,945(L) 32,758,602(S) | 5.85 1.11 | |
| 15/06/2026 | UBS Group AG | 1316(L) | 5,278,184(L) | 181,882,945(L) 32,723,602(S) | 6.16 1.11 | |
| 22/05/2026 | UBS Group AG | 1402(S) | +417,000(S) | 191,143,845(L) 29,636,502(S) | 6.48 1.00 | |
| 21/05/2026 | 曲繼廣 | 1113(L) | +1,300,000(L) | HKD2.373(L) | 1,262,492,000(L) | 42.78 |
| 20/05/2026 | 曲繼廣 | 1113(L) | +2,000,000(L) | HKD2.313(L) | 1,261,192,000(L) | 42.73 |
| 19/05/2026 | 曲繼廣 | 1113(L) | +2,000,000(L) | HKD2.353(L) | 1,259,192,000(L) | 42.66 |
| 18/05/2026 | 曲繼廣 | 1113(L) | +2,500,000(L) | HKD2.330(L) | 1,257,192,000(L) | 42.60 |
| 05/05/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,100,000(L) | HKD2.353(L) | 911,604,000(L) | 30.89 |
| 05/05/2026 | 曲繼廣 | 1113(L) | +1,100,000(L) | HKD2.353(L) | 1,254,692,000(L) | 42.51 |
| 17/04/2026 | 曲繼廣 | 1113(L) | +1,450,000(L) | HKD2.497(L) | 1,253,592,000(L) | 42.48 |
| 17/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,450,000(L) | HKD2.497(L) | 910,504,000(L) | 30.85 |
| 16/04/2026 | 曲繼廣 | 1113(L) | +1,450,000(L) | HKD2.512(L) | 1,252,142,000(L) | 42.43 |
| 16/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,450,000(L) | HKD2.512(L) | 909,054,000(L) | 30.80 |
| 10/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,800,000(L) | HKD2.545(L) | 907,604,000(L) | 30.75 |
| 1 2 3 4 | ||||||
| 備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
| (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 25/09/2026 14:20 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
新聞
股票
期貨期權N
權證
ETF
美股
A股
外匯黃金
加密貨幣
基金
MPF